Skip navigation

Industry Best Practices for Financial Excellence, Compliance and Strategic Decision-Making

March 16-18, 2020
  • Philadelphia, PA

Providing the Highest Level of Education, Networking and Industry Insights for Excellence in Finance, Accounting and Business Strategy.

The industry’s event of the year for CPE education, networking and peer benchmarking, CBI’s 16th Life Sciences Accounting & Reporting Congress drives practice alignment and business strategy. As the marketplace increases in complexity and technical standards change, Pharma/Biotech/Device Finance and Accounting leaders must stay ahead on regulations and trends. The Congress convenes over 100 speakers and over 500 attendees each year, with over 90% of the audience noting the event as a valuable must-attend meeting!

Company Perspectives, Regulatory Guidance & Audit/Advisory Insights on Hot Topics Such As:

  • SEC updates and comment letter review
  • FASB initiatives and new standards
  • Political environment, product pricing and healthcare reform
  • Accounting for outcomes-based contracts
  • Revenue recognition
  • Internal control and compliance
  • GTN forecasting, accounting and estimates
  • Business combinations, licensing and M&A
  • Financial planning and analysis
  • Product launch and commercialization strategies
  • Systems, data analytics and automation

2019 Attendee Acclaim:

The ability to connect with your life science peers and find out the latest thinking in accounting and reporting make this conference the best one for the year.

Anonymous

Must attend event – Perfect blend of technical education, healthcare innovation and networking opportunities.

Anonymous

Fantastic opportunity to meet industry colleagues and share ideas and information. I would encourage anyone in the life sciences industry to attend regardless of experience. Guaranteed something to be learned at any level.

Anonymous

A great event, wonderful to network and
meet so many US counterparts.

EMEA Controller, Alexion

The content of CBI's Life Sciences Accounting and Reporting Congress was fantastic. Meaningful content for most if not all of the primary business considerations for Life Sciences was provided - revenue recognition (GTN), new product commercialization, M&A, divestures (portfolio rationalization), valuation, capital structure, cybersecurity, blockchain, collaborations/licensing, R&D, SEC, etc. And, a welcoming atmosphere fostered natural collaboration amongst the attendees. An excellent conference!

Managing Director, PNC

16th Life Sciences Accounting & Reporting Congress

Industry Best Practices for Financial Excellence, Compliance and Strategic Decision-Making

Providing the Highest Level of Education, Networking and Industry Insights for Excellence in Finance, Accounting and Business Strategy.

The industry’s event of the year for CPE education, networking and peer benchmarking, CBI’s 16th Life Sciences Accounting & Reporting Congress drives practice alignment and business strategy. As the marketplace increases in complexity and technical standards change, Pharma/Biotech/Device Finance and Accounting leaders must stay ahead on regulations and trends. The Congress convenes over 100 speakers and over 500 attendees each year, with over 90% of the audience noting the event as a valuable must-attend meeting!

Company Perspectives, Regulatory Guidance & Audit/Advisory Insights on Hot Topics Such As:

  • SEC updates and comment letter review
  • FASB initiatives and new standards
  • Political environment, product pricing and healthcare reform
  • Accounting for outcomes-based contracts
  • Revenue recognition
  • Internal control and compliance
  • GTN forecasting, accounting and estimates
  • Business combinations, licensing and M&A
  • Financial planning and analysis
  • Product launch and commercialization strategies
  • Systems, data analytics and automation

2019 Attendee Acclaim:

The ability to connect with your life science peers and find out the latest thinking in accounting and reporting make this conference the best one for the year.

Anonymous

Must attend event – Perfect blend of technical education, healthcare innovation and networking opportunities.

Anonymous

Fantastic opportunity to meet industry colleagues and share ideas and information. I would encourage anyone in the life sciences industry to attend regardless of experience. Guaranteed something to be learned at any level.

Anonymous

A great event, wonderful to network and
meet so many US counterparts.

EMEA Controller, Alexion

The content of CBI's Life Sciences Accounting and Reporting Congress was fantastic. Meaningful content for most if not all of the primary business considerations for Life Sciences was provided - revenue recognition (GTN), new product commercialization, M&A, divestures (portfolio rationalization), valuation, capital structure, cybersecurity, blockchain, collaborations/licensing, R&D, SEC, etc. And, a welcoming atmosphere fostered natural collaboration amongst the attendees. An excellent conference!

Managing Director, PNC